Leerink Partners Adjusts Price Target on Boston Scientific to $55 From $60
MT newswire2026/10/09 13:4109:41 AM EDT, 10/09/2026 (MT Newswires) -- Boston Scientific (BSX) has an average rating of overweight and mean price target of $58.61, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 42.06, Change: +0.04, Percent Change: +0.08
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PS5 Pro is Sold Out Everywhere as GTA VI Pre-Load Starts Next Week
CryptoQuant analyst says the altcoin market cap has shrunk by about $20 billion

![Fu Peng: Pay attention to the potential shift in copper from stockpiling to bottleneck logic [Fu Peng Commentary]](https://img.bgstatic.com/external-content/5bba8cd4c8254af78616bb3a2e614b63.jpg?w=420&h=236&f=webp)
Ripple's Dubai Event Presence Gets High-Profile Boost From Emirates Chairman
